How Vaccines Are Made and Manufactured: Viral Vector Platform

Viral vector-based vaccines constitute a promising part of the biopharmaceutical pipeline, addressing many unmet indications. Some estimates show that half of the front runners of vaccine candidates for COVID-19 have used the viral vector platform. Moreover this is a complex platform with more than 40 vectors being used for both gene therapy and vaccines. Watch this video to learn how vaccines are manufactured using a viral-vector platform.